Skip to main content

Table 1 Clinical features of the asthmatic and COPD patients enrolled in the study

From: An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD

Patients’ characteristics

Asthma

COPD

Demographic data

Number of participants

15

22

Age (years)

53,7 ± 14,3

68,7** ± 7,1

Sex (male/female)

5/10

20/2

Smoking status

Never-smokers

10

1

Ex-smokers

4

15

Current-smokers

1

6

Lung function

FEV1 (% predicted)a

75,9 ± 16,4

43,8*** ± 21,2

FVC (% predicted)b

87,5 ± 17,3

72,3* ± 12,5

FEV1/FVC

0,88 ± 0,1

0,62* ± 0,2

  1. Data are expressed as numbers or mean ± standard deviation
  2. aForced expiratory volume in 1 s percentage predicted
  3. bForced vital capacity percentage predicted
  4. *p-value < 0.01 (asthma vs COPD)
  5. **p-value < 0.001 (asthma vs COPD)
  6. ***p-value < 0.0001